Z53 Therapeutics' Corporate Minority Round

Z53 Therapeutics raised a round of funding on March 01, 2016. Investors include BioMotiv.

Z53 Therapeutics aims to develop novel anti-cancer drugs that target tumors with p53 mutations.…

Articles about Z53 Therapeutics' Corporate Minority Round: